anti-SARS-CoV-2 vaccine (HK inno.N)

N/A

Report date: 2025/01/26 17:59:42

Base Information

Drug Nameanti-SARS-CoV-2 vaccine (HK inno.N)
Drug Alias Nameanti-SARS-CoV-2 vaccine (Korea Research Institute of Chemical Technology/CEVI)
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionCoronavirus spike glycoprotein modulators
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Severe Acute Respiratory Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKorea Research Institute Of Chemical Technology
China Registration ClassN/A

Develop Information

Active CompaniesHK Inno N Corp
Inactive CompaniesKorea Research Institute Of Chemical Technology
Active IndicationsCoronavirus Disease 2019 (COVID-19)Severe Acute Respiratory Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A